An experimental drug stops advanced breast cancer from progressing in some people with tumors that have grown resistant to ...
A groundbreaking international study has found that imlunestrant plus abemaciclib significantly improved progression-free survival (PFS) versus imlunestrant monotherapy in patients with estrogen ...
Researchers from Memorial Sloan Kettering Cancer Center to present the latest advances in blood cancer during The American ...
From life-saving medicine to gratitude for caregivers and a surprise romance, these stories remind us of the power of human connection.
Ready to start planning your care? Call us at 800-525-2225 to make an appointment.
Research at MSK Our research impact Research topics Core facilities & resources ...
Research at MSK Our research impact Research topics Core facilities & resources ...
En esta información se explica cómo tener una mutación en el gen FLCN puede afectarles a usted y a su familia.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback